ArticleAging2023

PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.

Qinzheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.